Alfred Chung, MD
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma (NCT06348108) | Alfred Chung, MD | 2025-07-28 |
| Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE) (NCT05486481) | Alfred Chung, MD | 2024-01-08 |
| Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies (NCT05191472) | Alfred Chung, MD | 2022-05-03 |
Track Alfred Chung, MD automatically
Every clearance here is in the API, with alerts when new ones post.